Literature DB >> 3148471

Effect of acute administration of propranolol and atenolol on baroreflex function in normal man.

A H Deering1, D W Harron, J G Riddell, R G Shanks.   

Abstract

The acute administration of the beta-adrenoceptor antagonists propranolol (80 mg) and atenolol (50 mg) on baroreflex function were investigated in healthy volunteers. Two h after administration both propranolol and atenolol significantly prolonged the supine R-R interval (1126, 1128 ms respectively) compared to placebo (1012 ms); systolic arterial pressure also fell (102.9, 102.0 mm Hg respectively) compared to placebo (112.6 mm Hg). Baroreflex function, assessed using glyceryl trinitrate to deactivate the baroreceptors was unchanged by these drugs compared to placebo. Baroreflex sensitivity (slope of the linear regression line relating R-R interval to systolic blood pressure) using phenylephrine to activate the baroreceptors, was also unchanged (17.2, 17.9 ms/mm Hg respectively) compared to placebo (19.9 ms/mm Hg). However both regression lines were shifted (p less than 0.05) to the left compared to placebo.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3148471     DOI: 10.1007/bf00637596

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  37 in total

1.  Haemodynamic and baroreceptor responses to beta-adrenoceptor blocking agents in rabbits with cardiopulmonary bypass.

Authors:  A Friggi; A M Chevalier-Cholat; J Torresani
Journal:  Eur J Pharmacol       Date:  1977-10-01       Impact factor: 4.432

2.  Effect of d,l-propranolol on renal sympathetic baroreflex properties and aortic baroreceptor activity.

Authors:  P K Dorward; P I Korner
Journal:  Eur J Pharmacol       Date:  1978-11-01       Impact factor: 4.432

Review 3.  Circulatory reflexes from mechanoreceptors in the cardio-aortic area.

Authors:  C L Pelletier; J T Shepherd
Journal:  Circ Res       Date:  1973-08       Impact factor: 17.367

4.  Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension.

Authors:  L Hansson; A J Zweifler; S Julius; S N Hunyor
Journal:  Acta Med Scand       Date:  1974 Jul-Aug

5.  Inhibition of the carotid sinus reflex by the chronic administration of propranolol.

Authors:  D Dunlop; R G Shanks
Journal:  Br J Pharmacol       Date:  1969-05       Impact factor: 8.739

6.  The place of alpha-adrenoceptor and beta-adrenoceptor blockade in the treatment of hypertension.

Authors:  F Gross
Journal:  Br J Clin Pharmacol       Date:  1982-06       Impact factor: 4.335

7.  Beta-adrenoceptor blockers and the blood-brian barrier.

Authors:  G Neil-Dwyer; J Bartlett; J McAinsh; J M Cruickshank
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

8.  The effects of beta-adrenoceptor blockade on renin, angiotensin, aldosterone and catecholamines at rest and during exercise.

Authors:  P J Lijnen; A K Amery; R H Fagard; T M Reybrouck; E J Moerman; A F De Schaepdryver
Journal:  Br J Clin Pharmacol       Date:  1979-02       Impact factor: 4.335

9.  The role of the baroreceptor reflex in the cardiovascular effects of propranolol in the conscious spontaneously hypertensive rat.

Authors:  H A Struyker-Boudier; J F Smits; H Van Essen
Journal:  Clin Sci (Lond)       Date:  1979-02       Impact factor: 6.124

10.  Baroreflex "resetting" by arterial hypoxia in the renal and cardiac sympathetic nerves of the rabbit.

Authors:  M Iriki; P Dorward; P I Korner
Journal:  Pflugers Arch       Date:  1977-07-29       Impact factor: 3.657

View more
  2 in total

1.  Potential autonomic risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.

Authors:  William Maixner; Joel D Greenspan; Ronald Dubner; Eric Bair; Flora Mulkey; Vanessa Miller; Charles Knott; Gary D Slade; Richard Ohrbach; Luda Diatchenko; Roger B Fillingim
Journal:  J Pain       Date:  2011-11       Impact factor: 5.820

2.  Cardiac regulation in the socially monogamous prairie vole.

Authors:  Angela J Grippo; Damon G Lamb; C Sue Carter; Stephen W Porges
Journal:  Physiol Behav       Date:  2006-11-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.